TrialCard Incorporated, a full-service life sciences commercialization partner, today announced that Scott Dulitz has been promoted to Chief Executive Officer by the Company's Board of Directors. Mr. Dulitz, a twenty-year veteran of the pharma services industry, joined TrialCard in 2015 and most recently served as President and Chief Strategy Officer.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.